Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2007 2
2008 6
2009 3
2013 2
2016 1
2017 1
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean marinapapoutsaki (5 results)?
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.
Torres T, Puig L, Vender R, Yeung J, Carrascosa JM, Piaserico S, Gisondi P, Lynde C, Ferreira P, Bastos PM, Dauden E, Leite L, Valerio J, Del Alcázar-Viladomiu E, Rull EV, Llamas-Velasco M, Pirro F, Messina F, Bruni M, Licata G, Ricceri F, Nidegger A, Hugo J, Mufti A, Daponte AI, Teixeira L, Balato A, Romanelli M, Prignano F, Gkalpakiotis S, Conrad C, Lazaridou E, Rompoti N, Papoutsaki M, Nogueira M, Chiricozzi A. Torres T, et al. Among authors: papoutsaki m. Am J Clin Dermatol. 2022 Nov;23(6):891-904. doi: 10.1007/s40257-022-00722-y. Epub 2022 Aug 17. Am J Clin Dermatol. 2022. PMID: 35976568
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
Tsiogka A, Gregoriou S, Stratigos A, Soulaidopoulos S, Rompoti N, Panagakis P, Papoutsaki M, Kostakis P, Kontochristopoulos G, Tsioufis K, Campanati A, Offidani A, Vlachopoulos C, Rigopoulos D. Tsiogka A, et al. Among authors: papoutsaki m. Biomedicines. 2023 Jan 23;11(2):318. doi: 10.3390/biomedicines11020318. Biomedicines. 2023. PMID: 36830855 Free PMC article. Review.
Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A. Papoutsaki M, et al. BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638. BioDrugs. 2013. PMID: 23990278 Review.
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis.
Rompoti N, Stefanaki I, Panagakis P, Papoutsaki M, Politou M, Vavouli C, Befon A, Kousta F, Lazou E, Zaimi M, Koumprentziotis IA, Chasapi V, Rigopoulos D, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: papoutsaki m. J Eur Acad Dermatol Venereol. 2024 Mar 20. doi: 10.1111/jdv.19956. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38506605 No abstract available.
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks.
Rompoti N, Politou M, Stefanaki I, Vavouli C, Papoutsaki M, Neofotistou A, Rigopoulos D, Stratigos A, Nicolaidou E. Rompoti N, et al. Among authors: papoutsaki m. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):689-697. doi: 10.1111/jdv.18825. Epub 2023 Jan 4. J Eur Acad Dermatol Venereol. 2023. PMID: 36562663
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.
Torres T, Chiricozzi A, Puig L, Lé AM, Marzano AV, Dapavo P, Dauden E, Carrascosa JM, Lazaridou E, Duarte G, Carvalho AVE, Romiti R, Rompoti N, Teixeira L, Abreu M, Ippoliti E, Maronese CA, Llamas-Velasco M, Vilarrasa E, Del Alcázar E, Daponte AI, Papoutsaki M, Carugno A, Bellinato F, Gisondi P. Torres T, et al. Among authors: papoutsaki m. Am J Clin Dermatol. 2024 Mar;25(2):333-342. doi: 10.1007/s40257-024-00845-4. Epub 2024 Jan 24. Am J Clin Dermatol. 2024. PMID: 38265746 Free PMC article.
Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.
Klavdianou K, Stavropoulou M, Panagakis P, Papoutsaki M, Panagiotopoulos A, Koutsianas C, Stratigos A, Rigopoulos D, Vassilopoulos D. Klavdianou K, et al. Among authors: papoutsaki m. Rheumatol Int. 2022 Jun;42(6):1035-1041. doi: 10.1007/s00296-022-05126-z. Epub 2022 Apr 18. Rheumatol Int. 2022. PMID: 35435445
25 results